查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571427

球囊瓣環成形術設備市場規模、佔有率、趨勢分析報告：按應用、最終用途、地區和細分市場預測，2024-2030 年

Balloon Valvuloplasty Devices Market Size, Share & Trends Analysis Report By Application (Aortic Valve Stenosis, Pulmonary Valve Stenosis), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

球囊瓣環成形設備市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球球囊瓣環成形設備市場規模預計將達到30.2億美元，2024年至2030年複合年成長率為4.1%。

包括瓣膜性心臟病在內的心血管疾病的盛行率不斷上升、新產品的推出、監管部門的核准和先進的醫療基礎設施正在推動北美對球囊瓣環成形設備的需求。風濕性心臟疾病（RHD）是一種嚴重的心血管疾病，是由風濕熱引起的心臟瓣膜損傷引起的。

根據美國心臟協會 2024 年 4 月發布的報告，瓣膜性心臟病 (VHD) 是美國最普遍的健康狀況之一，影響約 2.5% 的成年人口。主動脈瓣和二尖瓣疾病是最常見的 VHD 類型，而球囊瓣環成形等有效的治療方案對於解決這一日益嚴重的健康問題至關重要。

提高意識和篩檢計劃正在推動市場成長。例如，2024 年 9 月，世界心臟中心發起了宣傳活動，強調瓣膜性心臟病的盛行率不斷上升，預計到 2040 年將增加一倍，到 2060 年將增加兩倍。這些努力凸顯了透過定期健康檢查及早發現的重要作用。該組織旨在向公眾通報病情和可用的治療方法，例如球囊瓣環成形。

瓣環成形設備市場報告亮點

  • 從應用來看，主動脈瓣狹窄領域佔比最大，2023年將超過64%。全球瓣膜性心臟病盛行率的上升和技術進步正在推動該領域的成長。
  • 以最終用途分類，醫院業務在 2023 年佔據最大收益佔有率，達到 57.4%。全球瓣膜性心臟病的盛行率不斷上升，需要醫院內部採用先進的解決方案來有效管理病患照護。
  • 由於包括瓣膜性心臟病在內的心血管疾病病例不斷增加，北美在 2023 年以 41.4% 的佔有率佔據市場主導地位。產品發布、監管核准和先進的醫療基礎設施正在推動對球囊瓣環成形設備的需求。
  • 球囊瓣環成形術設備市場包括 B. Braun Interventional Systems, Inc.、BD Interventional、Edwards Lifesciences、Boston Scientific Corporation、Getinge、Toray International America, Inc.、Stryker、BrosMed Medical、Medtronic、Terumo Corporation、Philips 等。其中。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章全球球囊瓣環成形設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 瓣環成形設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章球囊瓣環成形設備市場：應用估計和趨勢分析

  • 球囊瓣環成形術設備市場：應用儀表板
  • 球囊瓣環成形設備市場：應用變化分析
  • 按申請，2018-2030
  • 主動脈瓣狹窄
  • 肺動脈瓣狹窄

第5章球囊瓣環成形設備市場：最終用途估計與趨勢分析

  • 瓣環成形設備市場：最終用途儀表板
  • 瓣環成形瓣膜成形術設備市場：最終用途變化分析
  • 按最終用途分類，2018-2030
  • 醫院
  • 日間手術中心 (ASC)
  • 心導管實驗室

第6章 球囊瓣環成形設備市場：區域估計與趨勢分析

  • 全球球囊瓣環成形設備市場：區域儀表板
  • 按地區分類，2018-2030
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章 競爭格局

  • 主要製造商的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • Key customers
    • Key company market share analysis, 2023
    • B. Braun Interventional Systems, Inc.
    • BD Interventional
    • Edwards Lifesciences
    • Boston Scientific Corporation
    • Getinge
    • Toray International America, Inc.
    • Stryker
    • BrosMed Medical
    • Medtronic
    • Terumo Corporation
    • Philips
Product Code: GVR-4-68040-438-3

Balloon Valvuloplasty Devices Market Growth & Trends:

The global balloon valvuloplasty devices market size is expected to reach USD 3.02 billion by 2030, registering a CAGR of 4.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of cardiovascular diseases, including valvular heart diseases, new product launches, regulatory approvals, and advanced healthcare infrastructure, drives the demand for balloon valvuloplasty devices in North America. Rheumatic heart disease (RHD) is a serious cardiovascular condition that arises from damage to the heart valves due to rheumatic fever.

According to a report published by the American Heart Association in April 2024, valvular heart disease (VHD) is among the most prevalent health conditions in the U.S., affecting about 2.5% of the adult population. Aortic and mitral valve diseases are the most diagnosed types of VHD, further emphasizing the critical need for effective treatment options like balloon valvuloplasty devices to address this growing health concern.

Increasing awareness and screening programs fuel the market's growth. For instance, in September 2024, the Global Heart Hub initiated campaigns highlighting the rising prevalence of heart valve disease, which is expected to double by 2040 and triple by 2060. These efforts stress the critical role of early detection through regular medical check-ups. The organization aims to inform the public about the symptoms and available treatments, such as balloon valvuloplasty.

Balloon Valvuloplasty Devices Market Report Highlights:

  • Based on application, the aortic valve stenosis segment held the largest share, over 64%, in 2023. The global rise in the incidence of valvular heart diseases and technological advancements drive the segment's growth
  • Based on end use, the hospital segment held the largest revenue share at 57.4% in 2023. The rising incidence of valvular heart diseases globally necessitates advanced solutions within hospitals to manage patient care effectively
  • North America dominated the market with a share of 41.4% in 2023, owing to the rising cases of cardiovascular diseases, including valvular heart diseases. Product launches, regulatory approvals, and advanced healthcare infrastructure drive the demand for balloon valvuloplasty devices
  • Market players operating in the balloon valvuloplasty devices market include B. Braun Interventional Systems, Inc., BD Interventional, Edwards Lifesciences, Boston Scientific Corporation, Getinge, Toray International America, Inc., Stryker, BrosMed Medical, Medtronic, Terumo Corporation, Philips

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application Segment
    • 2.2.2. End-use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Balloon Valvuloplasty Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of valvular heart diseases
      • 3.2.1.2. Technological advancements in balloon valvuloplasty devices
      • 3.2.1.3. Increasing awareness and screening programs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost associated with the devices and procedures
      • 3.2.2.2. Regulatory compliance
  • 3.3. Balloon Valvuloplasty Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Balloon Valvuloplasty Devices Market: Application Estimates & Trend Analysis

  • 4.1. Balloon Valvuloplasty Devices Market: Application Dashboard
  • 4.2. Balloon Valvuloplasty Devices Market: Application Movement Analysis
  • 4.3. Balloon Valvuloplasty Devices Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Aortic Valve Stenosis
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Pulmonary Valve Stenosis
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Balloon Valvuloplasty Devices Market: End-use Estimates & Trend Analysis

  • 5.1. Balloon Valvuloplasty Devices Market: End-use Dashboard
  • 5.2. Balloon Valvuloplasty Devices Market: End-use Movement Analysis
  • 5.3. Balloon Valvuloplasty Devices Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Ambulatory Surgical Centers (ASCs)
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Cardiac Catheterization Labs
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Balloon Valvuloplasty Devices Market: Regional Estimates & Trend Analysis by Country, Application, & End-use

  • 6.1. Global Balloon Valvuloplasty Devices Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. B. Braun Interventional Systems, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. BD Interventional
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Edwards Lifesciences
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Boston Scientific Corporation
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Getinge
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Toray International America, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Stryker
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. BrosMed Medical
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Medtronic
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Terumo Corporation
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Philips
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. Global balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 4. Global balloon valvuloplasty devices market, by end-use, 2018 - 2030
  • Table 5. Global balloon valvuloplasty devices market, by region, 2018 - 2030 (USD Million)
  • Table 5. North America balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 7. North America balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 8. U.S. balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 9. U.S. balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 10. Canada balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 11. Canada balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 12. Mexico balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 13. Mexico balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 14. Europe balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 16. Europe balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 17. U.K. balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 18. U.K. balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 19. Germany balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 20. Germany balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 21. France balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 22. France balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 23. Italy balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 24. Italy balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 25. Spain balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 26. Spain balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 27. Denmark balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 28. Denmark balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 29. Sweden balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 30. Sweden balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 31. Norway balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 32. Norway balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 36. Japan balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 37. Japan balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 38. China balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 39. China balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 40. India balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 41. India balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 42. Australia balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 43. Australia balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 44. Australia balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 45. Thailand balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 46. Thailand balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 47. South Korea balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 48. South Korea balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 49. Latin America balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 50. Latin America balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 51. Latin America balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 52. Brazil balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 53. Brazil balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 54. Argentina balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 55. Argentina balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 56. MEA balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 57. MEA balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 58. MEA balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 59. South Africa balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 60. South Africa balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 63. UAE balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 64. UAE balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 66. Kuwait balloon valvuloplasty devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 67. Participant's overview
  • Table 68. Financial performance
  • Table 69. Key companies undergoing expansions
  • Table 70. Key companies undergoing acquisitions
  • Table 71. Key companies undergoing collaborations
  • Table 72. Key companies launching new products
  • Table 73. Key companies undergoing partnerships
  • Table 74. Key companies undertaking other strategies

List of Figures

  • Fig. 1 Balloon valvuloplasty devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Balloon valvuloplasty devices market revenues, 2023, (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Balloon valvuloplasty devices market application outlook:
  • Fig. 14 Balloon valvuloplasty devices market: application movement analysis
  • Fig. 15 Global aortic valve stenosis market, 2018 - 2030 (USD Million)
  • Fig. 16 Global pulmonary valve stenosis market, 2018 - 2030 (USD Million)
  • Fig. 17 Balloon valvuloplasty devices market end-use outlook:
  • Fig. 18 Balloon valvuloplasty devices market: end-use movement analysis
  • Fig. 19 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 20 Global ambulatory surgical centers (ASCs) market, 2018 - 2030 (USD Million)
  • Fig. 21 Global cardiac catheterization labs market, 2018 - 2030 (USD Million)
  • Fig. 22 Regional market place: Key takeaways
  • Fig. 23 North America balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 25 Canada balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 26 Mexico balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 27 Europe balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Germany balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 29 U.K. balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 30 France balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 31 Italy balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Spain balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Asia Pacific balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Japan balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 35 China balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 36 India balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Australia balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Latin America balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Brazil balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 40 MEA balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 41 South Africa balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Saudi Arabia balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Market Participant Categorization
  • Fig. 44 Strategy mapping